CardiAI Inc.: federal grants and contributions: 5 agreements; $1.7M value; 3 departments; 5 programs.
Assay record ASY-CA-1RWJQJ90VP · Cite as: Assay Systems, “CardiAI Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/cardiai-inc/
Support for CardiAI to continue operations during the COVID-19 pandemic.
The objective of this project is to design and develop a bedside/at home cardiac biomarker-based technology and device to achieve better outcomes for patients living with Heart Failure. CardiAi's POC development plan includes the development of a disposable cardiac biomarker sensor based testing strip and a small format hand held electronic reader.
As part of the international consortium project, the firm will co-develop an optical sensor patch-based ambulatory blood pressure monitor that represents a next generation of cuffless ABPM for 24-hour Blood Pressure, Heart Rate, ECG, and Oxygen saturation measurement for real-time patient monitoring.
The YEP employee will be assisting the technical team on the development and testing of a proprietary Point-of-Care device for heart disease management.
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.